Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,354,998 papers from all fields of science
Search
Sign In
Create Free Account
lornoxicam
Known as:
Lornoxicamum
, xefocam
, Chlortenoxicam
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (2)
Anti-Inflammatory Agents, Non-Steroidal
Piroxicam
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Proniosomal gel for transdermal delivery of lornoxicam: optimization using factorial design and in vivo evaluation in rats
Hiral Shah
,
Anroop B Nair
,
Jigar N. Shah
,
P. Bharadia
,
Bandar E Al-dhubiab
DARU Journal of Pharmaceutical Sciences
2019
Corpus ID: 59526059
Clinical utility of lornoxicam in oral therapy is primarily restricted by the low solubility and gastric adverse effects. This…
Expand
Highly Cited
2015
Highly Cited
2015
Oro-dental mucoadhesive proniosomal gel formulation loaded with lornoxicam for management of dental pain
G. Abdelbary
,
M. H. Aburahma
Journal of liposome research
2015
Corpus ID: 5438471
Abstract Oro-dental diseases are generally associated with pain that is controlled using oral tablets containing NSAIDs…
Expand
Highly Cited
2015
Highly Cited
2015
Formulation and characterization of solid lipid nanoparticles, nanostructured lipid carriers and nanoemulsion of lornoxicam for transdermal delivery
Ü. Gönüllü
,
M. Üner
,
G. Yener
,
E. Karaman
,
Z. Aydoğmuş
Acta Pharmaceutica
2015
Corpus ID: 4989413
Abstract Solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC) and nanoemulsion (NE) of lornoxicam (LRX) were…
Expand
2015
2015
Preparation and pharmacokinetics evaluation of oral self-emulsifying system for poorly water-soluble drug Lornoxicam
Fei Li
,
Shuangshuang Song
,
+4 authors
Xing-gang Yang
Drug Delivery
2015
Corpus ID: 22619211
Abstract The present work was performed aiming to develop a new solid self-emulsifying system (SMEDDS) for poorly water-soluble…
Expand
Highly Cited
2014
Highly Cited
2014
Evaluation of Skin Permeation and Analgesic Activity Effects of Carbopol Lornoxicam Topical Gels Containing Penetration Enhancer
S. Al-suwayeh
,
E. Taha
,
Fahad M. Al-Qahtani
,
Mahrous O. Ahmed
,
M. Badran
TheScientificWorldJournal
2014
Corpus ID: 18615535
The current study was designed to develop a topical gel formulation for improved skin penetration of lornoxicam (LOR) for…
Expand
Highly Cited
2011
Highly Cited
2011
Global patterns of genetic diversity and signals of natural selection for human ADME genes.
Jing Li
,
Luyong Zhang
,
Hang Zhou
,
M. Stoneking
,
K. Tang
Human Molecular Genetics
2011
Corpus ID: 11626572
Genetic polymorphisms in many genes related to drug absorption, distribution, metabolism and excretion (ADME genes) contribute to…
Expand
Highly Cited
2000
Highly Cited
2000
Lornoxicam, a new potent NSAID with an improved tolerability profile.
S. Radhofer-Welte
,
X. Rabasseda
Drugs of Today
2000
Corpus ID: 22024680
Lornoxicam is a member of the oxicam group of nonsteroidal antiinflammatory drugs (NSAIDs). Oxicams have potent antiinflammatory…
Expand
Highly Cited
1999
Highly Cited
1999
Efficacy and Tolerability of Lornoxicam versus Tramadol in Postoperative Pain
H. Staunstrup
,
J. Ovesen
,
U. T. Larsen
,
K. Elbæk
,
U. Larsen
,
K. Krøner
Journal of clinical pharmacology
1999
Corpus ID: 22882833
This randomized double‐blind study compared the analgesic efficacy and tolerability of intramuscular lornoxicam and tramadol in…
Expand
Review
1998
Review
1998
Clinical Pharmacokinetics of Lornoxicam
N. Skjodt
,
N. Davies
Clinical Pharmacokinetics
1998
Corpus ID: 46662001
SummaryLornoxicam (chlorotenoxicam) is a nonsteroidal anti-inflammatory drug (NSAID) of the oxicam class. Unlike other oxicams…
Expand
Highly Cited
1996
Highly Cited
1996
A multicenter, randomized, double blind study comparing lornoxicam with diclofenac in osteoarthritis.
B. Kidd
,
W. Frenzel
Journal of Rheumatology
1996
Corpus ID: 21849794
OBJECTIVE To compare the efficacy and tolerability of lornoxicam and diclofenac in the treatment of patients with osteoarthritis…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE